MitoChem Therapeutics

0 followers

‌

With funding from Foundation Fighting Blindness and the NIH the company synthesized compounds that demonstrate promise for treating vision loss from retinitis pigmentosa, age-related macular degeneration and glaucoma.

Industries

Headquarters

Employees

Links

Org chart

Michael Voevodsky

President & CEO

Michael Voevodsky

Collapse

Bärbel Rohrer

Co-Founder & CSO

Craig Beeson

Co-founder

Dan Adams

Director

Teams

Leadership Team

3 members

Similar companies

Synthekine

3 followers

Forge Biologics

2 followers

Obsidian Therapeutics

1 follower

Caribou Biosciences

1 follower

Mineralys Therapeutics

1 follower

Slingshot Biosciences

1 follower

Elektrofi

1 follower

BioAge

3 followers

Kula Bio

2 followers

Astria Therapeutics

1 follower

Thermo Fisher Scientific

149 followers

Discover companies